The lung biopsy device acquired by Covidien in its superDimension acquisition is included in new guidelines from the American College of Chest Physicians.
Covidien (NYSE:COV) said the lung biopsy device it acquired along with superDimension last year was included in new guidelines from the American College of Chest Physicians.
The superDimension electromagnetic navigation bronchoscopy system is designed to use the lungs own airways to obtain biopsies of suspect tissue earlier than other treatment options.
Covidien restates its financial results for its fiscal 2nd quarter ahead of the spinout of its Mallinckrodt pharmaceuticals business, expected next month.
Covidien (NYSE:COV) re-stated its financial results for the fiscal 3rd quarter ended March 29, in anticipation of the planned spinout of its Mallinckrodt pharmaceuticals business next month.
Covidien said the new numbers reflect the pharma unit as a discontinued operation, with COV shareholders slated to receive a tax-free distribution, according to a regulatory filing.
Stryker (NYSE:SYK) CEO Kevin Lobo told an investors conference audience in Las Vegas yesterday that the medical device company is still in the mergers & acquisitions hunt, even after its newsmaking buyouts of China's Trauson Holdings, Israel's Orthovita and Surpass Medical.
A list of some of the tax tabs for medical device companies for the medical device excise tax during Q1
In January 2013, Medical device companies began paying a 2.3% excise tax on U.S. Sales in order to pay for the Patient Protection and Affordable Care Act.
The levy is expected to generate some $30 billion over the next 10 years.
MassDevice.com is tracking the tally paid by several medical device companies, based on quarterly earnings report for the first quarter of 2013. We will update the list as more companies returns file in.
Tallies based on companies with Q1 earnings ended on March 31, 2013
Edwards Lifesciences said its CFO, Thomas Abate, plans to retire once a replacement is found later this year.
Edwards Lifesciences (NYSE:EW) said its finance chief, Thomas Abate, plans to retire later this year after a replacement is found.
The Irvine, Calif.-based medical device company said Abate, 60, will stay on as CFO while the search goes on. Edwards hired Peter Crist of Crist/Kolder Associates to assist in the quest, according to a press release.
The FDA warns hospitals to watch out for 1 lot of Covidien surgical staples that are labeled “sterile” but were stolen prior to undergoing sterilization.
FDA regulators warned healthcare providers this week that thieves had gotten away with 1 lot of Covidien's (NYSE:COV) Endo GIA Articulating 60-3.5 Surgical Stapler Reloads.
In addition to being stolen, the devices were labeled " ready for use" but were taken before the staples were actually sterilized, the FDA warned. . The agency's Office of Criminal Investigation is looking into the theft.